MoneyWorks4Me

Dr. Reddy’s Laboratories informs about media release

21 Mar 2026 Evaluate
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release titled “Dr. Reddy’s Laboratories announces launch of India’s first DCGI-approved Semaglutide injection ‘Obeda®’ for Type 2 Diabetes.’

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..